Funded Projects

In this highly interdisciplinary project, PhD candidate Alberto Tono is pursuing the novel application of combined EEG and immersive reality to streamline workflows in building design and construction.

Fang Wang has been developing novel steady-state EEG techniques to reveal the underlying neural dynamics involved in the acquisition of reading skills in children. She will use the Koret award to extend her findings in typically developing children to children with dyslexia, illustrating how cortical challenges in the temporal dynamics of visual processing can contribute to dyslexia.

This team is working on understanding which patients with mild cognitive impairment (MCI) will best benefit from cognitive training. They are researching a multimodal approach to understand this question and will use their Koret pilot grant award to evaluate high-density EEG biomarkers for successful cognitive training in MCI. 

This project aims to identify brain-based EEG markers of self-efficacy and self-regulation, which are the two critical treatment targets for people with chronic pain and comorbid heavy alcohol use. Such objective markers will assist in accurate diagnosis and assessment of treatment responses, which may enable a precision medicine approach for chronic pain and substance use disorders. 

This team will use their Koret pilot grant award to study if language difficulties in children with epilepsy are caused by excessive connectivity in the brain. The team previously found that elevated connectivity is associated with poorer language, and that inhibitory transcranial magnetic stimulation (TMS) can reduce connectivity.

This team is developing a cutting-edge mixed reality application to improve the targeted delivery of transcranial magnetic stimulation (TMS). TMS is increasingly being used as a treatment for psychiatric conditions, but the success of the treatment depends critically on its precise delivery.

This team is developing new transcranial magnetic stimulation methods that optimize neuromodulation effects using music-induced brain state dynamics.

This team aims to use the power of artificial intelligence to make new findings about brain aging, with the goal of boosting brain repair and resilience. They are particularly interested in spatial changes in the brain during aging. Their goal is to understand how aging renders the brain susceptible to injuries that accentuate neurodegenerative diseases.

The intricate workings of signaling pathways are well-established with regard to neurodevelopment. Yet, the implications of these pathways for sustaining brain health and resilience during the aging process are not clear.

Memories are stored at synapses and circuits, which tragically are pruned and deconstructed in Alzheimer's disease (AD). Genetic mutations including APP generate high levels of soluble oligomeric beta amyloid (oAbeta42), leading to insoluble beta amyloid plaques - hallmarks of late-stage disease. Clinical trials have designed "plaque-busting" drugs assuming that plaques cause disease.

It has been appreciated for decades years that cognitive decline and dementia are frequently accompanied by changes that cause proteins within brain cells to clump abnormally into structures called neurofibrillary tangles. Resilient brains are better able to resist this process but the underlying mechanisms for why individuals’ brains are more or less resilient are not fully understood.

Myelin, traditionally thought of as the brain's electrical insulator, has emerged as an active and dynamic regulator of brain functions including neuroprotection, learning, and memory. Myelin dysfunction and loss is increasingly found to be central to brain aging and neurodegenerative diseases including Alzheimer's.

Recent data suggest that increased circulation of cerebrospinal fluid (CSF) to clear the brain and spinal cord of waste is associated with improved outcomes in aging and recovery from brain injury, suggesting that inducing CSF clearing could enhance brain resilience. However, a therapeutic modality for directly inducing CSF clearing has not been available.

Current treatments for neurodegenerative disorders (proteinopathies) offer limited efficacy and typically target specific genetic forms. The goal of this research project is to discover targets shared across proteinopathies and advance the development of early diagnostic/prognostic tools and disease-modifying pan-proteinopathy approaches.

Brain resilience, the ability to withstand adverse outcomes despite significant risk factors, is crucial in late-onset Alzheimer’s disease (AD), where the Apolipoprotein E4 (APOE4) gene is a major risk factor. Carrying APOE4 increases AD risk up to 15-fold compared to the ApoE3 allele.

The ketogenic diet, fasting, and ketone supplements switch the body's fuel source from carbs to fats, a state known as ketosis. This switch can be good for your brain, helping to keep it healthy and resilient to damage. In ketosis, your liver makes a special fat-derived fuel called beta-hydroxybutyrate, or BHB for short.

Normal aging and neurodegenerative disease are typically characterized by accumulation of waste products inside the brain and in particular by aggregation of various types of proteins like Amyloid-beta outside of cells or the proteins Tau, alpha-synuclein, and TDP-43 inside cells.

Parkinson’s disease (PD) is the second most common neurodegenerative disease, characterized by progressive motor deficits such as tremor, muscle stiffness, and slowness of movement, and affects 6 million worldwide. Despite ongoing efforts to discover the mechanisms underlying this disease, PD remains an incurable disorder.

More and more studies suggest that infections may be an important cause of dementia and possibly brain aging more generally. The most convincing evidence exists for herpesviruses, which “hibernate” in the nervous system. Recently,  an innovative causal approach in data from the United Kingdom has been used to suggest that shingles (herpes zoster) vaccination prevents or delays dementia.

This project focuses on the brain’s “glycocalyx”—a complex network of sugars on the cell surface, which plays a crucial role in many brain functions including how neurons connect and communicate and how memories are formed and stored.

This project's goal is to enhance brain resilience by promoting vascular brain health during aging. The research team's overarching hypothesis is that many people experience cognitive decline and dementia due to pathological aging.

The cerebrospinal fluid (CSF) influences the development, maturation, and aging of the nervous system in ways that are not fully understood. TurboID, a synthetically engineered enzyme, can label CSF proteins to track their sources and development, providing insight into the roles the CSF plays in development, health, and disease.

RNA sensors are a cutting edge tool in synthetic biology for probing complex molecular pathways and creating “smart” molecular circuits in cells. This team leverages state-of-the-art synthetic biology tools to understand how oligodendrocytes contribute to Alzheimer’s disease and other demyelinating disorders.

Psychedelics profoundly alter human consciousness through activation of 5-HT2A receptor proteins in the brain. This team aims to develop a molecular probe to permanently illuminate 5-HT2A receptors without modifying their function or expression, allowing scientists to better study the effects of psychedelics on these receptors.